|
NIPBL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.689800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.638400E-01 |
| Normal-vs-Stage2 |
6.794800E-01 |
| Normal-vs-Stage3 |
5.215600E-01 |
| Normal-vs-Stage4 |
3.031000E-01 |
| Stage1-vs-Stage2 |
3.695200E-01 |
| Stage1-vs-Stage3 |
1.543440E-01 |
| Stage1-vs-Stage4 |
5.909600E-02 |
| Stage2-vs-Stage3 |
9.808200E-01 |
| Stage2-vs-Stage4 |
7.451200E-01 |
| Stage3-vs-Stage4 |
6.403000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.726800E-01 |
| Normal-vs-AfricanAmerican |
5.768800E-01 |
| Normal-vs-Asian |
1.533790E-01 |
| Caucasian-vs-AfricanAmerican |
5.939000E-01 |
| Caucasian-vs-Asian |
1.395580E-01 |
| AfricanAmerican-vs-Asian |
1.093400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.453400E-01 |
| Normal-vs-Female |
8.791200E-01 |
| Male-vs-Female |
4.873400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.157200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.347400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.322200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.756370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.808000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.547200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.919600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.187200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.041220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.105600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.175570E-01 |
| Normal-vs-Grade 2 |
2.982600E-01 |
| Normal-vs-Grade 3 |
2.518800E-01 |
| Normal-vs-Grade 4 |
1.343420E-01 |
| Grade 1-vs-Grade 2 |
3.651400E-01 |
| Grade 1-vs-Grade 3 |
2.123700E-02 |
| Grade 1-vs-Grade 4 |
7.221900E-03 |
| Grade 2-vs-Grade 3 |
2.241100E-03 |
| Grade 2-vs-Grade 4 |
2.140900E-03 |
| Grade 3-vs-Grade 4 |
5.154600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.707200E-01 |
| Normal-vs-ccB subtype |
4.662400E-01 |
| ccA subtype-vs-ccB subtype |
1.599910E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.148400E-01 |
| Normal-vs-N1 |
5.130400E-01 |
| N0-vs-N1 |
5.741400E-01 |
|
|
